Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 328 entries
View as:

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

Phase: N/A Priority: Normal
NCT ID: NCT01503541 Org: User:
Start: 12/31/11 End: 06/30/12 Due: 06/30/13

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Phase: N/A Priority: Normal
NCT ID: NCT06769126 Org: User:
Start: 09/08/25 End: 12/31/29 Due: 12/31/30

S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

Phase: N/A Priority: Normal
NCT ID: NCT01061437 Org: User:
Start: 06/30/09 End: 07/31/11 Due: 07/31/12

S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003369 Org: User:
Start: 08/31/98 End: 07/31/04 Due: 07/31/05

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00049400 Org: User:
Start: 10/31/03 End: 12/31/07 Due: 12/31/08

S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00026156 Org: User:
Start: 11/30/01 End: 11/30/08 Due: 11/30/09

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT05096663 Org: User:
Start: 03/15/22 End: 12/01/27 Due: 12/01/28

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06616584 Org: User:
Start: 07/11/25 End: 12/31/28 Due: 12/31/29

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00985699 Org: User:
Start: 04/30/09 End: 06/30/14 Due: 06/30/15

Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03757949 Org: User:
Start: 03/05/19 End: 01/01/27 Due: 01/01/28

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00840177 Org: User:
Start: 12/10/09 End: 10/21/21 Due: 10/21/22

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00016939 Org: User:
Start: 05/31/01 End: 04/30/06 Due: 04/30/07

SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT00002900 Org: User:
Start: 02/28/97 End: - Due: -

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00068601 Org: User:
Start: 10/31/03 End: 09/30/16 Due: 09/30/17

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03694002 Org: User:
Start: 03/20/19 End: 03/03/25 Due: 03/03/26

S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission

Phase: N/A Priority: Normal
NCT ID: NCT00227474 Org: User:
Start: - End: - Due: -

S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00054054 Org: User:
Start: 04/30/03 End: - Due: -

S9925: Collecting and Storing Samples From Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00920010 Org: User:
Start: 09/30/00 End: 01/31/13 Due: 01/31/14

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00103233 Org: User:
Start: 12/31/04 End: 04/30/06 Due: 04/30/07

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00005597 Org: User:
Start: 04/30/00 End: 10/31/05 Due: 10/31/06

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03851445 Org: User:
Start: 02/06/19 End: 01/28/29 Due: 01/28/30

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00096031 Org: User:
Start: 10/31/04 End: 01/31/10 Due: 01/31/11

S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00265785 Org: User:
Start: 07/31/06 End: 07/31/11 Due: 07/31/12

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT03499808 Org: User:
Start: 06/06/18 End: 07/31/25 Due: 07/31/26

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01903811 Org: User:
Start: 10/31/13 End: 03/07/19 Due: 03/07/20